FIORINO, GIONATA

FIORINO, GIONATA  

Mostra records
Risultati 1 - 20 di 41 (tempo di esecuzione: 0.351 secondi).
Titolo Data di pubblicazione Autore(i) File
A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn’s disease: a single center experience. 1-gen-2010 Fiorino, Gionata; Bonifacio, C; Szabò, H; Padrenostro, M; Balzarini, L; Repici, A; Malesci, A; Daneses,
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 1-gen-2010 Fiorino, Gionata; C., Bonifacio; F., Minuti; A., Repici; A., Spinelli; Fries, Walter; A., Malesci; L., Balzarini; S., Danese
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 1-gen-2011 G. Fiorino; C. Bonifacio; F. Minuti; A. Repici; A. Spinelli; W. Fries; A. Malesci; L. Balzarini; S. Danese.
Acute Severe Colitis: Infliximab and/or Cyclosporine? 1-gen-2011 Fabro, M; Szabo, H; Terrosu, G; Avellini, C; Tabuso, M; Fiorino, Gionata; Sorrentino, D.
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 1-gen-2011 Fiorino, Gionata; H., Szabò; Fries, Walter; A., Malesci; L., Peyrin Biroulet; S., Danese
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 1-gen-2011 G. Fiorino; H. Szabò; W. Fries; A. Malesci; L. Peyrin-Biroulet; S. Danese.
Adalimumab in ulcerative colitis: hypes and hopes 1-gen-2011 Fiorino, Gionata; Peyrin Biroulet, L; Repici, A; Malesci, A; Danese, S.
Anti-TNF Therapy in Inflammatory Bowel Diseases 1-gen-2010 Fiorino, Gionata; Danese, S; Peyrin Biroulet, L.
Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. 1-gen-2010 Sorrentino, D; Paviotti, A; Fiorino, Gionata
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 1-gen-2010 Repici, A; Fiorino, Gionata; Pagano, N; Romeo, F; Carlino, A; Arosio, M; Strangio, G; Rando, G; Ferreira, Dp; Malesci, A; Danese, S.
Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. 1-gen-2011 Fiorino, Gionata; Cesarini, M; Danese, S.
Different Segmental Transit Time (TT) Through the Small Bowel May Affect Wireless Capsule (WC) Endoscopy 1-gen-2009 Pallotta, N; Fiorino, Gionata; Romeo, E; Cesarini, M; Ciccantelli, B; Vincoli, G; Vernia, P; Carabotti, M; Cucchiara, S; Corazziari, E.
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 1-gen-2020 Privitera, Giuseppe; Onali, Sara; Pugliese, Daniela; Renna, Sara; Savarino, Edoardo; Viola, Anna; Ribaldone, Davide Giuseppe; Buda, Andrea; Bezzio, Cristina; Fiorino, Gionata; Fantini, Massimo Claudio; Scaldaferri, Franco; Guidi, Luisa; Danese, Silvio; Gasbarrini, Antonio; Orlando, Ambrogio; Armuzzi, Alessandro
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 1-gen-2012 Fiorino, Gionata; Peyrin Biroulet, L.; Naccarato, Patrizia; Szabò, H; Sociale, O. R; Vetrano, S.; Fries, Walter; Montanelli, A.; Repici, A.; Malesci, A.; Danese, S.
Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? 1-gen-2010 Fiorino, Gionata; Rovida, S; Correale, C; Malesci, A; Danese, S.
Familial aggregation in inflammatory bowel disease: Is it genes or environment? 1-gen-2011 Nunes, T; Fiorino, Gionata; Danese, S; Sans, M.
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 1-gen-2011 Rahier, J-F.; Papay, P.; Salleron, J.; Sebastian, S.; Marzo M, M.; Peyrin-Biroulet, L.; Garcia-Sanchez, V.; Fries, W.; van Asseldonk, D.P.; Farkas, K.; de Boer, N.K.H.; Sipponen, T.; Ellul, P.; Louis, E.; Peake, S.T.C.; Kopylov, U.; Maul, J.; Makhoul, B.; Fiorino, G.; Yazdanpanah, Y.; Chaparro, M.; For, the European Crohn’s and Colitis Organisation (ECCO).
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 1-gen-2010 Szabò, H; Fiorino, Gionata; Danese, S.
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 1-gen-2009 Danese, S; Fiorino, Gionata; Vetrano, S; Rando, G; Pagano, N; Romeo, F; Omodei, P; Repici, A; Rutella, S; Malesci, A.
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. 1-gen-2011 Rutella, S; Fiorino, Gionata; Vetrano, S; Correale, C; Spinelli, A; Pagano, N; Arena, V; Maggiano, N; Repici, A; Malesci, A; Danese, S.